OTCMKTS:BNXTF BioNxt Solutions (BNXTF) Stock Price, News & Analysis $0.23 0.00 (0.00%) (As of 07/3/2024 ET) Add Compare Share Share Today's Range$0.23▼$0.2350-Day Range$0.13▼$0.3052-Week Range$0.00▼$0.57VolumeN/AAverage Volume1,141 shsMarket Capitalization$24.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get BioNxt Solutions alerts: Email Address Ad Digital Mavericks Media1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income every month.Click here to check it out. About BioNxt Solutions Stock (OTCMKTS:BNXTF)BioNxt Solutions Inc. engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains. In addition, the company offers psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. Further, it provides analytical testing and consulting services. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.Read More BNXTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BNXTF Stock News HeadlinesApril 26, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Solutions Announces ODF Cladribine Update and FinancingMarch 18, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports Commercialization of ODF Cladribine Product for MS Next StepsJuly 4, 2024 | Golden Crest (Ad)Urgent: Safeguard Your Finances from Biden NOWHave you heard about Executive Order 14067? This lesser-known order introduced the Digital Dollar, an alarming plan aimed at controlling your spending. And it gets even more concerning: in November, the Federal Government and banks initiated a test program to implement the Digital Dollar.March 13, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports Successful Results From ODF Cladribine PK StudyMarch 4, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports Completion of ODF Cladribine PK StudyFebruary 19, 2024 | msn.comBioNxt Solutions finalizes debt settlement agreementFebruary 16, 2024 | finance.yahoo.comBioNxt Solutions Finalizes AgreementFebruary 7, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports Successful Results From ODF Cladribine Toxicity StudyJuly 4, 2024 | Golden Crest (Ad)Urgent: Safeguard Your Finances from Biden NOWHave you heard about Executive Order 14067? This lesser-known order introduced the Digital Dollar, an alarming plan aimed at controlling your spending. And it gets even more concerning: in November, the Federal Government and banks initiated a test program to implement the Digital Dollar.February 7, 2024 | finance.yahoo.comBioNxt Reports Successful Results From ODF Cladribine Toxicity StudyJanuary 30, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private PlacementJanuary 30, 2024 | finance.yahoo.comBioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private PlacementJanuary 5, 2024 | ca.finance.yahoo.comBioNxt Solutions Inc. (BNXT.CN)December 23, 2023 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and FinancingDecember 21, 2023 | finance.yahoo.comBioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and FinancingDecember 12, 2023 | finance.yahoo.comBioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery ProductsDecember 9, 2023 | finance.yahoo.comBioNxt Solutions Announces Completion of Debenture and Interest Settlement and Issuance of Finder’s WarrantsNovember 24, 2023 | benzinga.comBionxt Solutions Announces Convertible Debenture and Interest SettlementNovember 20, 2023 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis TreamentNovember 20, 2023 | finance.yahoo.comBioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis TreamentNovember 16, 2023 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports on New Cladrabine ODF Product Development and Commercialization ProgramNovember 15, 2023 | finance.yahoo.comBioNxt Reports on New Cladrabine ODF Product Development and Commercialization ProgramNovember 13, 2023 | finance.yahoo.comBioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple SclerosisNovember 6, 2023 | benzinga.comBioNxt Solutions berichtet über CPHI-Kongress in BarcelonaNovember 6, 2023 | finance.yahoo.comBioNxt Solutions Reports on Barcelona CPHI ConferenceOctober 27, 2023 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private PlacementOctober 27, 2023 | finance.yahoo.comBioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private PlacementSee More Headlines Receive BNXTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioNxt Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/29/2024Today7/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:BNXTF CUSIPN/A CIKN/A Webwww.xphyto.com Phone780-818-6422FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,720,000.00 Net Margins-3,054.17% Pretax Margin-3,011.46% Return on EquityN/A Return on Assets-555.96% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.15 Sales & Book Value Annual Sales$280,000.00 Price / Sales89.02 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-5.64Miscellaneous Outstanding Shares110,520,000Free FloatN/AMarket Cap$24.93 million OptionableNot Optionable Beta0.86 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Hugh A. D. Rogers B.Sc. (Age 44)LL.B, President, CEO & Director Comp: $175.9kMr. Patrick Joseph Meagher C.A. (Age 38)CPA, CA, CPA, CFO & Director Comp: $52.67kDr. Florian A. SahrHead of Project ManagementKey CompetitorsKaryopharm TherapeuticsNASDAQ:KPTIBrainsWayNASDAQ:BWAYAthira PharmaNASDAQ:ATHACervoMedNASDAQ:CRVORAPT TherapeuticsNASDAQ:RAPTView All Competitors BNXTF Stock Analysis - Frequently Asked Questions How have BNXTF shares performed in 2024? BioNxt Solutions' stock was trading at $0.3809 at the start of the year. Since then, BNXTF stock has decreased by 40.8% and is now trading at $0.2255. View the best growth stocks for 2024 here. Are investors shorting BioNxt Solutions? BioNxt Solutions saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,000 shares, a decline of 56.5% from the May 31st total of 2,300 shares. Based on an average daily volume of 1,200 shares, the short-interest ratio is currently 0.8 days. View BioNxt Solutions' Short Interest. How were BioNxt Solutions' earnings last quarter? BioNxt Solutions Inc. (OTCMKTS:BNXTF) issued its quarterly earnings results on Wednesday, May, 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. How do I buy shares of BioNxt Solutions? Shares of BNXTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BNXTF) was last updated on 7/4/2024 by MarketBeat.com Staff From Our Partners1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredUrgent: Safeguard Your Finances from Biden NOWHave you heard about Executive Order 14067? This lesser-known order introduced the Digital Dollar, an alarming...Golden Crest | SponsoredRe: We’re giving you all this for less than a pair of socksThe Only Trading Tool You'll Need This Year Forget juggling multiple subscriptions and confusing indicator...StockEarnings | SponsoredNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNxt Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNxt Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNXTF Stock Alerts